At3g15200 Antibody

What is the At3g15200 protein and why is it studied?

At3g15200 encodes a putative pentatricopeptide repeat-containing protein in Arabidopsis thaliana with homologs in other plant species such as Prunus persica . This protein belongs to a family of RNA-binding proteins primarily involved in organellar gene expression. Research on At3g15200 contributes to our understanding of plant RNA metabolism, organelle function, and developmental pathways in plants.

What applications can At3g15200 antibodies be used for?

At3g15200 antibodies can be utilized for multiple research applications including:

• Western blotting for protein expression analysis

• Immunoprecipitation for protein-protein or protein-RNA interaction studies

• Immunofluorescence for subcellular localization

• Flow cytometry for cellular expression analysis

• ChIP assays if the protein has DNA-binding capabilities

As with any antibody application, method-specific validation is crucial for reliable results .

What sample types are suitable for At3g15200 antibody detection?

At3g15200 antibodies can typically be used with:

• Plant tissue lysates (particularly from Arabidopsis and other model plants)

• Recombinant protein samples

• Fixed tissue sections for immunohistochemistry

• Isolated organelles (particularly chloroplasts or mitochondria)

The sample preparation method should be optimized based on the specific application and antibody being used .

How should I validate an At3g15200 antibody before experimental use?

Comprehensive validation should include:

• Genetic approach: Testing the antibody in wild-type and knockout/knockdown samples to confirm specificity

• Orthogonal validation: Comparing antibody staining with protein/gene expression using antibody-independent methods such as targeted mass spectrometry

• Immunocapture followed by mass spectrometry: To identify captured proteins and confirm target specificity

• Cross-reactivity testing: Especially important if working with homologs across plant species

What controls should be included when using At3g15200 antibodies?

Essential controls include:

• Positive control: Samples with confirmed At3g15200 expression

• Negative control: Knockout/knockdown samples or tissues known not to express At3g15200

• Secondary antibody-only control: To assess background signal

• Isotype control: Especially important for immunoprecipitation experiments

• Blocking peptide control: If available, to confirm epitope specificity

Data from controlled validation studies shows that approximately 50% of commercial antibodies fail to meet basic characterization standards, resulting in estimated financial losses of $0.4-1.8 billion per year in the US alone .

What dilution ranges are typically effective for At3g15200 antibodies?

Optimal dilutions vary by application but typically fall within these ranges:

Always perform a dilution series to determine optimal concentration for your specific experimental conditions .

How can I address cross-reactivity issues with At3g15200 antibodies?

Cross-reactivity problems can be approached through:

• Increased washing stringency: More frequent and longer washes with higher detergent concentrations

• Alternative blocking agents: Testing different blockers (BSA, milk, commercial alternatives)

• Pre-adsorption: Incubating antibody with non-specific proteins to reduce non-specific binding

• Genetic verification: Using tissues/cells from knockout models to confirm bands/signals are specific

• Epitope mapping: Identifying the specific region recognized to assess potential cross-reactivity

Research shows that even antibodies recommended based on genetic validation approaches can still exhibit off-target binding, with approximately 11% failing to detect their intended targets in controlled studies .

How do I interpret discrepancies between At3g15200 antibody results and gene expression data?

When antibody-based protein detection contradicts transcript-level data:

• Post-transcriptional regulation: Consider regulation mechanisms between transcription and translation

• Protein stability/turnover: Assess whether protein degradation rates differ from mRNA

• Antibody specificity issues: Re-validate the antibody using orthogonal methods

• Epitope masking: Investigate if protein interactions or modifications may prevent antibody binding

• Method-specific artifacts: Different sample preparation methods may affect epitope accessibility

It's important to note that RNA expression does not necessarily correlate strongly with protein expression. As noted in search result , this is a weakness of orthogonal validation approaches that compare antibody staining to transcript levels .

What factors might affect At3g15200 antibody detection in different plant tissues?

Several factors can impact antibody performance across tissues:

• Tissue-specific protein modifications: Post-translational modifications may alter epitope recognition

• Tissue fixation methods: Different fixatives can affect epitope accessibility

• Protein complex formation: Tissue-specific protein interactions may mask antibody binding sites

• Expression levels: Detection thresholds may vary across tissues with different expression levels

• Extraction efficiency: Different tissues may require optimized protein extraction protocols

Studies show that antigen conformation can vary substantially between different tissue preparation methods, requiring validation for each specific application context .

How can At3g15200 antibodies be used to study protein-protein interactions in developmental pathways?

To investigate protein interactions:

• Co-immunoprecipitation (Co-IP): Pull down At3g15200 and identify interacting partners by Western blot or mass spectrometry

• Proximity ligation assay (PLA): Visualize interactions in situ with a second antibody against suspected interacting proteins

• Immunoprecipitation followed by mass spectrometry (IP-MS): Identify novel interaction partners in an unbiased manner

• ChIP-seq: If At3g15200 protein has DNA-binding properties, map genomic binding sites

• FRET/FLIM microscopy: Using fluorescently-labeled antibodies to detect protein proximities in living systems

Research on other plant proteins demonstrates that antibody-based approaches can reveal regulatory networks, such as the WUSCHEL-CLAVATA feedback mechanism that maintains stem cell populations .

What considerations are important when using At3g15200 antibodies in mutant backgrounds?

When working with genetic mutants:

• Confirm absence/reduction of protein: Verify knockout/knockdown efficiency before further analysis

• Consider compensatory mechanisms: Related proteins may be upregulated in mutant backgrounds

• Evaluate epitope alterations: Mutations may affect the antibody binding site

• Control for background effects: Use appropriate genetic controls (e.g., wild-type siblings)

• Address developmental timing: Sample at equivalent developmental stages as phenotypes may vary

As seen in studies of ERF transcription factor mutants, analysis of expression profiles in multiple mutant backgrounds can reveal compensatory mechanisms and regulatory networks .

How can I develop a high-throughput screening assay using At3g15200 antibodies?

For developing screening platforms:

• Fluorescence-based detection: Using fluorescent secondary antibodies with automated imaging

• ELISA-based approaches: Developing quantitative assays for protein levels

• Multiplexed detection: Combining At3g15200 antibody with other markers for comprehensive analysis

• Microarray formats: Spotting samples for parallel processing

• Automation compatibility: Ensuring protocols work with liquid handling systems

The development of high-throughput methods for biological measurements from single samples has precedent in plant research, as demonstrated by chlorophyll measurement methods established for root explants .

How should At3g15200 antibody data be reported in publications to ensure reproducibility?

For reproducible reporting, include:

• Complete antibody identification: Catalog number, lot number, vendor, clone ID for monoclonal antibodies

• Validation evidence: Description of validation experiments performed

• Experimental conditions: Detailed protocols including dilutions, incubation times/temperatures

• Control descriptions: All controls used and their outcomes

• Original unprocessed images: Providing full blots/images in supplementary materials

Research indicates that inadequate antibody reporting contributes significantly to irreproducibility, with economic impacts estimated at $0.4-1.8 billion annually in the US alone .

What are the current standards for At3g15200 antibody validation in plant science?

Current best practices include:

• Testing in knockout/knockdown models: Confirming absence of signal in genetic nulls

• Independent detection methods: Correlating antibody signals with orthogonal approaches

• Cross-species validation: Confirming specificity across relevant plant species

• Application-specific validation: Validating separately for each experimental method

• Independent antibody validation: Using antibodies targeting different epitopes of the same protein

Recent studies indicate that only 50% of commercial antibodies meet basic characterization standards, highlighting the need for rigorous validation by end-users .

How can I contribute to community resources for At3g15200 antibody characterization?

Researchers can contribute through:

• Data sharing: Uploading validation data to public repositories

• Protocol publishing: Sharing optimized protocols on platforms like protocols.io

• Antibody rating: Providing feedback on commercial antibodies through repositories

• Publishing negative results: Reporting non-specific or poorly performing antibodies

• Using standardized identifiers: Implementing Research Resource Identifiers (RRIDs) in publications

Community-driven antibody validation efforts have been shown to significantly improve research reproducibility across various fields of biological research .

How might new antibody technologies improve At3g15200 protein research?

Emerging technologies include:

• Recombinant antibodies: Offering improved consistency compared to traditional polyclonal sources

• Single-domain antibodies (nanobodies): Providing access to previously inaccessible epitopes

• Engineered antibody fragments: Optimized for specific applications like live-cell imaging

• Multiplexed detection systems: Allowing simultaneous analysis of multiple proteins

• Proximity-dependent labeling: Using antibodies to target enzymes that label proximal proteins

Studies indicate that recombinant antibody technologies can substantially improve reproducibility compared to traditional antibody production methods .

What role might At3g15200 protein play in plant development and stress responses?

Current research suggests investigation of:

• RNA metabolism: Examining its role in RNA processing, stability, or translation

• Organelle function: Investigating its impact on chloroplast or mitochondrial gene expression

• Developmental pathways: Analyzing phenotypes in knockout/knockdown plants at various stages

• Stress response mechanisms: Examining expression changes under abiotic/biotic stresses

• Evolutionary conservation: Comparing function across plant species

Research on related plant proteins demonstrates the importance of properly validated antibodies in uncovering regulatory networks in plant development, as seen in studies of shoot apical meristem regulation .